Treatment of Anal HSIL in Patients With HIV Reduces Anal Cancer Risk
Among persons living with HIV who have anal HSILs, those who receive treatment have a lower rate of progression to anal cancer.
Among persons living with HIV who have anal HSILs, those who receive treatment have a lower rate of progression to anal cancer.
Researchers assessed the effect of human papillomavirus infection on the risk for sudden sensorineural hearing loss.
The impact of human papillomavirus (HPV) vaccination is increasing in the United States, with evidence of herd protection.
Researchers conducted a cross-sectional analysis that compared the performance of automated dual stain (DS) cytology with manual DS cytology for the detection of anal precancer among men who have sex with men living with HIV infection.
Researchers conducted a study that compared an HPV test-and-treat strategy with cytology-based screening on the risk of developing cervical cancer among women with HIV infection.
Might be too soon to tell impact on oropharyngeal and anal cancers
A new study projects that increasing HPV vaccination rates will trend toward reduced incidence of oropharyngeal cancer among younger adults until 2045.
Researchers conducted a study to determine the effect of a national human papillomavirus (HPV) immunization program on the incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia among young women in England.
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
Researchers conducted a study to determine the rates of human papillomavirus (HPV) infection among adolescent girls and young women in New York City who received the HPV vaccine following its approval in 2007.